RSV vaccine


anonymous

Guest
Again GSK uses it connections in the CDC to gain approval for their RSV vaccine for the 50-59 age group. What a bunch of crap. Again big pharma wins for corporate greed
 




I’d be more minded to think about the pre-F protein common to both, and who gets royalties on it.
I’d be looking in the NIH for starters. Money makes things happen.
 

















Write your reply...